chitosan has been researched along with Leptospirosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eed, EM; Elfasakhany, A; Govindan, P; Kandasamy, S; Pitchaikani, S; Pugazhendhi, A; Rajan, M; Shakila, H | 1 |
| Buaklin, A; Jacquet, A; Kerdkaew, R; Palaga, T; Patarakul, K; Sangjun, N; Umthong, S | 1 |
2 other study(ies) available for chitosan and Leptospirosis
| Article | Year |
|---|---|
Biomacromolecules of chitosan - Bacopa saponin based LipL32 gene delivery system for leptospirosis therapy.
Topics: Animals; Bacopa; Chitosan; Gene Transfer Techniques; Leptospirosis; Nanoparticles; Saponins; Spectroscopy, Fourier Transform Infrared | 2021 |
Immunogenicity of a DNA and Recombinant Protein Vaccine Combining LipL32 and Loa22 for Leptospirosis Using Chitosan as a Delivery System.
Topics: Animals; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Bacterial Proteins; Cell Line; Chitosan; Cytokines; Disease Models, Animal; Female; Humans; Immunity, Cellular; Immunity, Humoral; Immunization; Immunoglobulin G; Leptospira; Leptospirosis; Lipoproteins; Mice; Nanoparticles; Recombinant Proteins; T-Lymphocytes; Vaccination; Vaccines, DNA; Vaccines, Synthetic | 2015 |